» Articles » PMID: 9533877

Structural Diversity of Leucine-rich Repeat Proteins

Overview
Journal J Mol Biol
Publisher Elsevier
Date 1998 May 23
PMID 9533877
Citations 181
Authors
Affiliations
Soon will be listed here.
Abstract

The superfamily of leucine-rich repeat proteins can be subdivided into at least six subfamilies, characterised by different lengths and consensus sequences of the repeats. It was proposed that the repeats from different subfamilies retain a similar superhelical fold, but differ in the three-dimensional structures of individual repeats. The sequence-structure relationship of three new subfamilies was examined by molecular modelling. I provide structural models for the repeats of all subfamilies. The models enable me to explain residue conservations within each subfamily. Furthermore, the difference in the packing explains why the repeats from different subfamilies never occur simultaneously in the same protein. Finally, these studies suggest different evolutionary origins for the different subfamilies. The approach used for the prediction of the leucine-rich repeat protein structures can be applied to other proteins containing internal repeats of about 20 to 30 residue in length.

Citing Articles

Comprehensive analysis of LRRC42 as a potential biomarker and key cellular processes in cancer development.

Huang R, Yao J, Liu L, Li H, Huang B Sci Rep. 2025; 15(1):5169.

PMID: 39939664 PMC: 11821809. DOI: 10.1038/s41598-025-88467-6.


Phototropin2 3'UTR overlaps with the AT5G58150 gene encoding an inactive RLK kinase.

Labuz J, Banas A, Zglobicki P, Bazant A, Sztatelman O, Giza A BMC Plant Biol. 2024; 24(1):55.

PMID: 38238701 PMC: 10795372. DOI: 10.1186/s12870-024-04732-2.


Comparative genomics unveils extensive genomic variation between populations of Listeria species in natural and food-associated environments.

Liao J, Guo X, Li S, Anupoju S, Cheng R, Weller D ISME Commun. 2023; 3(1):85.

PMID: 37598265 PMC: 10439904. DOI: 10.1038/s43705-023-00293-x.


Small leucine rich proteoglycans: Biology, function and their therapeutic potential in the ocular surface.

Gesteira T, Verma S, Coulson-Thomas V Ocul Surf. 2023; 29:521-536.

PMID: 37355022 PMC: 11092928. DOI: 10.1016/j.jtos.2023.06.013.


LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy.

Luo L, Fu S, Du W, He L, Zhang X, Wang Y Front Immunol. 2023; 14:959868.

PMID: 36798137 PMC: 9928207. DOI: 10.3389/fimmu.2023.959868.